@wintertravel1980
I hadn’t realised that the vaccine effect In transmissibility was much more with the second dose than the first.
Hmmm.... I am not sure giving out second doses to over 50s and vulnerable individuals will help with reducing transmissions.
The younger groups are more socially active and therefore much more likely to drive transmissions. My personal view is that we should start surge vaccinating younger people. I appreciate vaccine supply is limited but if I had been in charge of the vaccination program, I would have offered AZ to those under 40s in hotspot areas who are willing to take it. I am ready to bet there will be demand.
From the yellow card report:
"This safety update report is based on detailed analysis of data up to 5 May 2021. At this date, an estimated 11.4 million first doses of the Pfizer/BioNTech vaccine and 23.3 million first doses of the COVID-19 Vaccine AstraZeneca had been administered, and around 8.7 million and 7.5 million second doses of the Pfizer/BioNTech vaccine and COVID-19 Vaccine AstraZeneca respectively. An approximate 0.1 million first doses of the COVID-19 Vaccine Moderna have also now been administered."
Maximum 2.7m more Pfizer second doses to give, the majority of which would need to be held back anyway as they are due this month. We were on I think 10.6m Pfizer first doses by end of first week of March (from memory), so it's really a minimal effect if those go early.
Meanwhile 15.8m second doses of AZ that can be given out to increase immunity by an extra fraction. If mumsnet is representative then people under 40 wouldn't take AZ anyway, inappropriate messaging (IMO and not all UK) around very tiny risks has made that impossible.